Apolipoprotein E genotypes, circulating C-reactive protein and angiographic coronary artery disease: The Ludwigshafen Risk and Cardiovascular Health Study

Atherosclerosis

Volumn 215, Issue 2, 2011, Pages 487-493

  Grammer, Tanja B ^a   Hoffmann, Michael M ^b   Renner, Wilfried ^d   Kleber, Marcus E ^c   Winkelmann, Bernhard R ^e   Böhm, Bernhard O ^f   März, Winfried ^a,d,g  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c LURIC Nonprofit LLC   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e Cardiology Group   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g SYNLAB ACADEMY   (Germany)

Author keywords

Apolipoprotein E; C reactive protein; Coronary artery disease; Genetic polymorphism; Inflammation

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; ALLELE; ANALYSIS OF VARIANCE; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CLINICAL ASSESSMENT; CLINICAL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALLELES; APOLIPOPROTEINS E; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; RISK;

EID: 79953042529     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.01.005     Document Type: Article

References (30)

1. Kaptoge S., Di Angelantonio E., Lowe G., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2009, 375:132-140.
2. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
3. Danesh J., Pepys M.B. C-reactive protein and coronary disease: is there a causal link?. Circulation 2009, 120:2036-2039.
4. Davey Smith G., Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 2003, 32:1-22.
5. Crawford D.C., Sanders C.L., Qin X., et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006, 114:2458-2465.
6. Lange L.A., Carlson C.S., Hindorff L.A., et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006, 296:2703-2711.
7. Kathiresan S., Larson M.G., Vasan R.S., et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006, 113:1415-1423.
8. Kardys I., de Maat M.P., Uitterlinden A.G., Hofman A., Witteman J.C. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J 2006, 27:1331-1337.
9. Eklund C., Kivimaki M., Islam M.S., et al. C-reactive protein genetics is associated with carotid artery compliance in men in the Cardiovascular Risk in Young Finns Study. Atherosclerosis 2008, 196:841-848.
10. Zhang L., Kao W.H., Berthier-Schaad Y., et al. C-reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis 2007, 49:118-126.
11. Zacho J., Tybjaerg-Hansen A., Jensen J.S., et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008, 359:1897-1908.
12. Grammer T.B., März W., Renner W., Bohm B.O., Hoffmann M.M. C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study. Eur Heart J 2009, 30:170-182.
13. März W., Scharnagl H., Hoffmann M.M., Boehm B.O., Winkelmann B.R. The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen Risk and Cardiovascular Health Study). Eur Heart J 2004, 25:2109-2119.
14. Mahley R.W., Rall S.C. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000, 1:507-537.
15. Bennet A.M., Di Angelantonio E., Ye Z., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007, 298:1300-1311.
16. Winkelmann B.R., März W., Boehm B.O., et al. Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001, 2:S1-S73.
17. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
18. Zivelin A., Rosenberg N., Peretz H., et al. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 1997, 43:1657-1659.
19. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
20. Gronroos P., Raitakari O.T., Kahonen M., et al. Association of high sensitive C-reactive protein with apolipoprotein E polymorphism in children and young adults: the Cardiovascular Risk in Young Finns Study. Clin Chem Lab Med 2008, 46:179-186.
21. Timpson N.J., Lawlor D.A., Harbord R.M., et al. C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet 2005, 366:1954-1959.
22. Casas J.P., Shah T., Cooper J., et al. Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 2006, 35:922-931.
23. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195-2207.
24. Genser B., Grammer T.B., Stojakovic T., Siekmeier R., März W. Effect of HMG CoA reductase inhibitors on low-density lipoprotein cholesterol and C-reactive protein: systematic review and meta-analysis. Int J Clin Pharmacol Therap 2008, 46::497-510.
25. Block G., Dietrich M., Norkus E., et al. Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Epidemiology 2006, 17:404-412.
26. Carlson C.S., Aldred S.F., Lee P.K., et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005, 77:64-77.
27. Buchanan A.V., Weiss K.M., Fullerton S.M. Dissecting complex disease: the quest for the Philosopher's Stone?. Int J Epidemiol 2006, 35:562-571.
28. Tuzcu E.M., Kapadia S.R., Tutar E., et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001, 103:2705-2710.
29. Wolf-Maier K., Cooper R.S., Banegas J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289:2363-2369.
30. Hauner H, Koster I., von Ferber L. Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hesse/KV in Hesse. Dtsch Med Wochenschr 2003, 128:2632-2637.